PubMed COVID-19 Clinical Care

CONCLUSIONS: Reductions in virus and particle concentrations were observed on the inside of the face shield; however, viable virus was measured on the inside of the face shield, in the breathing zone of the HCP. Therefore, other exposure control

CONCLUSIONS: Baricitinib treatment was associated with more favorable respiratory improvement at day 7 when compared with tocilizumab, but no differences were observed up to day 28.

No abstract

[This corrects the article DOI: 10.2196/42717.].

Creutzfeldt-Jakob Disease (CJD) is a rare, rapidly progressive, and fatal neurodegenerative disorder. We describe a man whose initial manifestations of CJD occurred shortly after contracting Coronavirus disease 2019 (COVID-19). He first developed

CONCLUSIONS: Surge testing in Bedford reached a large number of people, was particularly successful at reaching people living in the most deprived areas, and identified cases that might have otherwise been missed. However, the testing did not reach

CONCLUSIONS: RR measurements using the wearable monitor were highly-correlated with medical-grade devices in various clinical settings.

CONCLUSIONS: This proof-of-concept study presents NLP methods as viable tools to access and utilize experience-based knowledge and value considerations, possibly contributing to robust, equitable, and applicable guidelines. They offer a way for

Intrinsically disordered regions (IDRs) are critical for cellular function, yet often appear to lack sequence conservation when assessed by multiple sequence alignments. This raises the question of if and how function can be encoded and preserved in

CONCLUSION: Examination performance was similar for students taking a flipped-classroom course online and on-campus. Further research using data from multiple courses or from the same cohort, randomized, is needed to improve the internal and external